Annika Auranen - UTU Research Portal

Annika Auranen

- Docent,
Department of Clinical Medicine (Faculty of Medicine)

anaura@utu.fi

Publications

1 of 2

A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)
- Clinical Cancer Research
Huhtinen K, Gidwani K, Kekki H, Hynninen J, Salminen L, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, Pettersson K
(Other publication)
The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer (2018)
- Oncology
Kemiläinen H., Huhtinen K., Auranen A., Carpén O., Strauss L., Poutanen M.
(A1 Refereed original research article in a scientific journal)
(18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer (2016)
- Gynecologic Oncology
Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J
(A1 Refereed original research article in a scientific journal)
A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)
- Clinical Chemistry
Gidwani Kamlesh, Huhtinen Kaisa, Kekki Henna, van Vliet Sandra, Hynninen Johanna, Koivuviita Niina, Perheentupa Antti, Poutanen Matti, Auranen Annika, Grenman Seija, Lamminmaki Urpo, Carpen Olli, van Kooyk Yvette, Pettersson Kim
(A1 Refereed original research article in a scientific journal)
Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)
- Clinical Cancer Research
Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O
(Other publication)
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen
(A1 Refereed original research article in a scientific journal)
Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy (2015)
- Cancer Research
Chen P, Huhtinen K, Kaipio K, Mikkonen P, Aittomaki V, Lindell R, Hynninen J, Auranen A, Grenman S, Lehtonen R, Carpen O, Hautaniemi S
(A1 Refereed original research article in a scientific journal)
Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma (2015)
- Gynecologic Oncology
Edqvist PHD, Huvila J, Forsstrom B, Talve L, Carpen O, Salvesen HB, Krakstad C, Grenman S, Johannesson H, Ljungqvist O, Uhlen M, Ponten F, Auranen A
(A1 Refereed original research article in a scientific journal)
High-grade serous ovarian cancer subtyping identifies pathways for targeted therapy (2014)
- European Journal of Cancer
Huhtinen K, Chen P, Mikkonen P, Kaipio K, Aittomaki V, Lindell R, Auranen A, Lehtonen R, Hautaniemi S, Carpen O
(Other publication)
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. (2014)
- Tumor Biology
Vallius Tuulia, Hynninen Johanna, Auranen Annika, Carpén Olli, Matomäki Jaakko, Oksa Sinikka, Virtanen Johanna, Grénman Seija
(A1 Refereed original research article in a scientific journal)